EPHA2 and sarcoma: While EphA2 has been identified as receptor for hepatitis C virus [30] and Kaposi’s sarcoma-associated herpes virus [27] binding and entry, this is the first time EphA2 has been shown to function as a receptor for a bacterial pathogen.